Products

Antibodies

Primary Antibodies

TNF ALPHA

Human

Mouse

Rabbit

Goat

Rat

Sheep

Unconjugated

IgG1

Monoclonal

Druggable Genome

Secreted Protein

Transcription Factors

Transmembrane

Jak-STAT signaling pathway

Cytokine-cytokine receptor interaction

T cell receptor signaling pathway

Hematopoietic cell lineage

Allograft rejection

Asthma

Cell adhesion molecules (CAMs)

Toll-like receptor signaling pathway

Autoimmune thyroid disease

Pathways in cancer

Complement and coagulation cascades

Fc epsilon RI signaling pathway

Focal adhesion

Hypertrophic cardiomyopathy (HCM)

Systemic lupus erythematosus

ECM-receptor interaction

NOD-like receptor signaling pathway

Neuroactive ligand-receptor interaction

Pathogenic Escherichia coli infection

Cytosolic DNA-sensing pathway

Dilated cardiomyopathy

ErbB signaling pathway

Gap junction

Graft-versus-host disease

MAPK signaling pathway

Small cell lung cancer

Acute myeloid leukemia

Adipocytokine signaling pathway

Apoptosis

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

Chronic myeloid leukemia

Colorectal cancer

Endometrial cancer

Fc gamma R-mediated phagocytosis

Glioma

Leukocyte transendothelial migration

Melanogenesis

Natural killer cell mediated cytotoxicity

Neurotrophin signaling pathway

Primary immunodeficiency

Prion diseases

Prostate cancer

RIG-I-like receptor signaling pathway

Regulation of actin cytoskeleton

TGF-beta signaling pathway

Wnt signaling pathway

Alzheimer's disease

Amyotrophic lateral sclerosis (ALS)

Antigen processing and presentation

B cell receptor signaling pathway

Bladder cancer

Calcium signaling pathway

Cell cycle

Chemokine signaling pathway

GnRH signaling pathway

Insulin signaling pathway

Long-term potentiation

Melanoma

Non-small cell lung cancer

Olfactory transduction

Oocyte meiosis

Pancreatic cancer

Progesterone-mediated oocyte maturation

Renal cell carcinoma

Thyroid cancer

Tight junction

Type I diabetes mellitus

Type II diabetes mellitus

VEGF signaling pathway

mTOR signaling pathway

2